1. Home
  2. MAIA vs MIND Comparison

MAIA vs MIND Comparison

Compare MAIA & MIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAIA
  • MIND
  • Stock Information
  • Founded
  • MAIA 2018
  • MIND 1987
  • Country
  • MAIA United States
  • MIND United States
  • Employees
  • MAIA N/A
  • MIND N/A
  • Industry
  • MAIA Biotechnology: Pharmaceutical Preparations
  • MIND Industrial Machinery/Components
  • Sector
  • MAIA Health Care
  • MIND Industrials
  • Exchange
  • MAIA Nasdaq
  • MIND Nasdaq
  • Market Cap
  • MAIA 46.7M
  • MIND 40.6M
  • IPO Year
  • MAIA 2022
  • MIND 1994
  • Fundamental
  • Price
  • MAIA $2.03
  • MIND $6.67
  • Analyst Decision
  • MAIA
  • MIND
  • Analyst Count
  • MAIA 0
  • MIND 0
  • Target Price
  • MAIA N/A
  • MIND N/A
  • AVG Volume (30 Days)
  • MAIA 319.8K
  • MIND 209.1K
  • Earning Date
  • MAIA 05-20-2025
  • MIND 06-09-2025
  • Dividend Yield
  • MAIA N/A
  • MIND N/A
  • EPS Growth
  • MAIA N/A
  • MIND N/A
  • EPS
  • MAIA N/A
  • MIND 4.32
  • Revenue
  • MAIA N/A
  • MIND $46,863,000.00
  • Revenue This Year
  • MAIA N/A
  • MIND $5.56
  • Revenue Next Year
  • MAIA N/A
  • MIND N/A
  • P/E Ratio
  • MAIA N/A
  • MIND $1.56
  • Revenue Growth
  • MAIA N/A
  • MIND 28.36
  • 52 Week Low
  • MAIA $1.40
  • MIND $3.05
  • 52 Week High
  • MAIA $5.99
  • MIND $11.10
  • Technical
  • Relative Strength Index (RSI)
  • MAIA 53.91
  • MIND 56.53
  • Support Level
  • MAIA $1.80
  • MIND $6.50
  • Resistance Level
  • MAIA $2.18
  • MIND $6.98
  • Average True Range (ATR)
  • MAIA 0.30
  • MIND 0.41
  • MACD
  • MAIA -0.01
  • MIND 0.10
  • Stochastic Oscillator
  • MAIA 30.29
  • MIND 66.24

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.

About MIND MIND Technology Inc. (DE)

MIND Technology Inc provides technology and solutions for exploration, survey, and defense applications in oceanographic, hydrographic, defense, seismic, and security industries. The Company operates in segments namely, Seamap Marine Products and Klein Marine Products helps manufacture and sell specialized, high-performance sonar and seismic equipment. The company generates more revenue from Seamap Marine Products. The company's geographical segments include the United States; Europe, Russia & CIS; Middle East & Africa; Asia-Pacific; and Canada & Latin America.

Share on Social Networks: